[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.166.5.76. Please contact the publisher to request reinstatement.
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Citations 0
Correction
June 2, 1999

Incorrect Data

JAMA. 1999;281(21):1989. doi:10.1001/jama.281.21.1989

In the Original Contribution entitled "The Cost-effectiveness of Preventing AIDS-Related Opportunistic Infections" published in the January 14, 1998, issue of THE JOURNAL (1998;279:130-136), the cost-effectiveness ratios in dollars for Pneumocystis carinii pneumonia and toxoplasmosis prophylaxis were incorrect. In Table 3 on page 133, the ratio should be 2300 (not 16,000) per quality-adjusted life-year saved. In Table 4 on page 134, in the analyses unadjusted for quality of life and assuming combination antiretroviral therapy, the ratios should be 1900 (not 13,000) per year of life saved; and 10,200 (not 22,000) per quality-adjusted life-year saved, respectively. In Table 6 on page 134, the ratio for strategy 2 should be 2300 (not 16,000) per quality-adjusted life-year saved. The revised data do not affect the article's policy conclusions.

×